We provide you with 20 years of free, institutional-grade data for ANIX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ANIX. Explore the full financial landscape of ANIX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Anixa Biosciences, Inc(NASDAQ:ANIX) 
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen rec...
Website: http://www.anixa.com
Founded: 1982
Full Time Employees: 7
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report about ANIX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.